January 2, 2018 08:01 AM ESTUpdated 02:18 PM
Financing
Startups

Ex-Pfiz­er CEO's start­up Cen­trex­ion gets $67M for PhI­II painkiller

Brittany Meiling

Cen­trex­ion Ther­a­peu­tics, a Boston-based start­up led by ex-Pfiz­er CEO Jeff Kindler, just raised $67 mil­lion to bring its painkiller drug in­to Phase III tri­als. If …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

Jazz wins ap­proval for bis­pe­cif­ic in bil­iary tract can­cer

No­var­tis seeks more bolt-on deals as it pur­chas­es neu­ro start­up for up to $1.1B

FDA ad­comm rais­es risk ques­tions on As­traZeneca’s An­dexxa

At Jef­feries, all that man­u­fac­tur­ers want to talk about is GLP-1s

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times